MENGA, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 4.612
NA - Nord America 1.115
AS - Asia 867
SA - Sud America 150
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 58
OC - Oceania 2
Totale 6.894
Nazione #
NL - Olanda 3.749
US - Stati Uniti d'America 1.061
RU - Federazione Russa 447
SG - Singapore 324
CN - Cina 158
IT - Italia 146
HK - Hong Kong 137
BR - Brasile 105
VN - Vietnam 104
DE - Germania 90
BJ - Benin 68
FR - Francia 50
KR - Corea 46
GB - Regno Unito 35
CA - Canada 29
IN - India 22
BD - Bangladesh 18
PL - Polonia 16
AR - Argentina 15
UA - Ucraina 15
MX - Messico 14
ES - Italia 13
JP - Giappone 13
FI - Finlandia 12
IQ - Iraq 8
MA - Marocco 8
LT - Lituania 7
ZA - Sudafrica 7
CO - Colombia 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
BO - Bolivia 5
CL - Cile 5
TH - Thailandia 5
AT - Austria 4
IE - Irlanda 4
SE - Svezia 4
BE - Belgio 3
GE - Georgia 3
ID - Indonesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TR - Turchia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TV - Tuvalu 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.837
Città #
Amsterdam 3.746
San Jose 287
Singapore 162
Hong Kong 137
Council Bluffs 127
Ashburn 98
Los Angeles 86
Columbus 71
Cotonou 68
Beijing 55
Moscow 54
Seoul 44
Lauterbourg 41
Munich 29
Santa Clara 28
Ho Chi Minh City 26
New York 26
Novara 26
Falkenstein 24
Boardman 23
Hanoi 22
Buffalo 21
Orem 16
Nuremberg 15
Warsaw 14
Tokyo 11
Tornaco 11
Helsinki 10
London 10
Phoenix 10
Toronto 10
Brooklyn 9
Frankfurt am Main 8
Mexico City 8
Milan 8
Turin 8
Vercelli 8
Dallas 7
Haiphong 7
St Louis 7
Assago 6
Boston 6
Brno 6
Chennai 6
Chicago 6
Da Nang 6
Montreal 6
São Paulo 6
Tianjin 6
Atlanta 5
Baghdad 5
Bari 5
Calgary 5
Houston 5
San Francisco 5
Santiago 5
Cape Town 4
City of London 4
Granada 4
Querétaro 4
Rome 4
Seattle 4
Stockholm 4
Brussels 3
Curitiba 3
Denver 3
Dublin 3
Guangzhou 3
Kansas City 3
Kutaisi 3
La Paz 3
Mumbai 3
Poplar 3
Porto Alegre 3
Redondo Beach 3
Agadir 2
Aparecida de Goiânia 2
Bang Lamung 2
Barnet 2
Biên Hòa 2
Buttapietra 2
Bắc Ninh 2
Cagliari 2
Camaçari 2
Casablanca 2
Cavallirio 2
Charleston 2
Ciudad del Este 2
Dayton 2
Dearborn 2
Delhi 2
Doha 2
Go Vap 2
Guayaquil 2
Hyderabad 2
Kolkata 2
Lissone 2
Mar del Plata 2
Medellín 2
Milwaukee 2
Totale 5.581
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.981
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.978
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy 105
Acetylation of Human Mitochondrial Citrate Carrier Modulates Citrate/Malate Exchange to Sustain NADPH Production During Macrophage Activation 94
Blockade of glutamine synthetase enhances inflammatory response 91
BLOCKADE OF GLUTAMINE SYNTHETASE SKEWS MACROPHAGES TOWARDS AN M1-LIKE PHENOTYPE AND INHIBITS TUMOR METASTASIS 85
inibitori del carrier del citrato nel trattamento dell'infiammazione 80
“The citrate-related inflammatory pathway” 79
BLOCKADE OF GLUTAMINE SYNTHETASE SKEWS MACROPHAGES TOWARDS AN M1-LIKE PHENOTYPE AND INHIBITS TUMOR METASTASIS 79
Histamine catabolism contributes to cardiac injury by sustaining monoamine oxidase-dependent oxidative stress 76
Acetylation of Human Mitochondrial Citrate Carrier Modulates Citrate/Malate Exchange to Sustain NADPH Production During Macrophage Activation 74
Impaired cAMP–PKA–CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia 72
BLOCKADE OF GLUTAMINE SYNTHETASE SKEWS MACROPHAGES TOWARDS AN M1-LIKE PHENOTYPE AND INHIBITS TUMOR METASTASIS 71
Editorial: Metabolism Meets Function: Untangling the Cross-Talk Between Signaling and Metabolism 71
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells 70
Cachexia, a systemic disease beyond muscle atrophy 70
ATP-citrate lyase is essential for macrophage inflammatory response 66
Glutamine synthetase: Localization dictates outcome 66
Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages 66
Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor 65
Glutamine synthetase desensitizes differentiated adipocytes to proinflammatory stimuli by raising intracellular glutamine levels 65
A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation 64
Acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate/malate exchange activity to sustain NADPH production during macrophage activation 62
FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells 62
Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury 61
Editorial: Understanding how myeloid cell development and function meet tissue distinct metabolic requirements 61
The mitochondrial citrate carrier: a new player in inflammation 60
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 59
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages 58
SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism 58
The citrate-related inflammatory pathway 56
SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency 54
Impact of immunometabolism on cancer metastasis: A focus on T cells and macrophages 54
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 53
The influence of fatty acid metabolism on T cell function in lung cancer 52
Mitochondrial carriers in inflammation induced by bacterial endotoxin and cytokines 52
Pharmacological targets of metabolism in disease: Opportunities from macrophages 52
Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? 52
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis 51
IκBα targeting promotes oxidative stress-dependent cell death 49
The J2-immortalized murine macrophage cell line displays phenotypical and metabolic features of primary BMDMs in their M1 and M2 polarization state 48
“Pharmacological Targeting of Glutamine Synthetase Skews Macrophages Toward An Inflammatory Phenotype and Inhibits Metastasis” 47
The mitochondrial citrate carrier: a new player in inflammation 47
MEF2C exon α: Role in gene activation and differentiation 44
The mitochondrial aspartate/glutamate carrier isoform 1 gene expression is regulated by CREB in neuronal cells 41
Metabolism and TAM functions—it takes two to tango 41
Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier 41
The contribution of the citrate pathway to oxidative stress in Down syndrome 35
The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication 31
null 23
Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spread 22
Totale 6.894
Categoria #
all - tutte 18.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024200 0 0 0 0 0 0 0 0 0 0 140 60
2024/2025626 25 0 63 9 21 33 46 61 137 55 25 151
2025/20265.855 94 84 131 212 247 148 264 302 3.870 163 258 82
2026/2027213 77 136 0 0 0 0 0 0 0 0 0 0
Totale 6.894